Carboxymethylcellulose-fucoidan dissolvable microneedle patches for minimally invasive melanoma treatment: Demonstration on a 3D bioprinted A375 cell line model Article Swipe
Ana C. Q. Silva
,
Maria C. Teixeira
,
Ana Jesus
,
Paulo Costa
,
Isabel F. Almeida
,
Patrícia Dias‐Pereira
,
Inês Correia‐Sá
,
Helena Oliveira
,
Armando J. D. Silvestre
,
Carla Vilela
,
Carmen S. R. Freire
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1016/j.ijbiomac.2025.145320
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1016/j.ijbiomac.2025.145320
Melanoma often requires adjuvant therapy to combat tumor proliferation and metastasis. In this context, microneedle systems (MNs) present a promising avenue for minimally invasive delivery of drugs or bioactive compounds with natural anticancer properties, targeting the deeper layers of the skin. Herein, we describe the fabrication of bioactive dissolving microneedles composed of carboxymethylcellulose (CMC) and fucoidan (Fuc) using a simple and eco-friendly micromolding technique. The microneedles showcased integral bodies and sharp tips with heights of 456 μm, and robust mechanical properties, reaching a maximum force of 1.07 N needle-1. Preliminary insertion tests in a polymeric skin model demonstrated the ability of CMC_Fuc MNs to penetrate up to 381 μm, further validated in ex vivo human skin samples with insertion depths of 325-453 μm. Dissolution studies in an agarose hydrogel skin model revealed the complete dissolution of the MNs tips within 12 min. In vitro cytotoxicity assays unveiled the antitumoral effect of the CMC_Fuc MNs on A375 melanoma cells, leading to a significant cell viability reduction in both a 2D cell culture (ca. 83 %) and a 3D bioprinted melanoma culture model (ca. 56 %), after 48 h. The CMC_Fuc microneedle systems show great promise for minimally invasive adjuvant treatment of melanoma.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.ijbiomac.2025.145320
- OA Status
- hybrid
- Cited By
- 1
- References
- 60
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4411343938
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4411343938Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.ijbiomac.2025.145320Digital Object Identifier
- Title
-
Carboxymethylcellulose-fucoidan dissolvable microneedle patches for minimally invasive melanoma treatment: Demonstration on a 3D bioprinted A375 cell line modelWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-06-16Full publication date if available
- Authors
-
Ana C. Q. Silva, Maria C. Teixeira, Ana Jesus, Paulo Costa, Isabel F. Almeida, Patrícia Dias‐Pereira, Inês Correia‐Sá, Helena Oliveira, Armando J. D. Silvestre, Carla Vilela, Carmen S. R. FreireList of authors in order
- Landing page
-
https://doi.org/10.1016/j.ijbiomac.2025.145320Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1016/j.ijbiomac.2025.145320Direct OA link when available
- Concepts
-
Fucoidan, 3D bioprinting, Chemistry, Biomedical engineering, Polysaccharide, Medicine, Tissue engineering, BiochemistryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1Per-year citation counts (last 5 years)
- References (count)
-
60Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4411343938 |
|---|---|
| doi | https://doi.org/10.1016/j.ijbiomac.2025.145320 |
| ids.doi | https://doi.org/10.1016/j.ijbiomac.2025.145320 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40532993 |
| ids.openalex | https://openalex.org/W4411343938 |
| fwci | 2.67550232 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000188 |
| mesh[1].descriptor_ui | D008545 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | drug therapy |
| mesh[1].descriptor_name | Melanoma |
| mesh[2].qualifier_ui | Q000473 |
| mesh[2].descriptor_ui | D008545 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | pathology |
| mesh[2].descriptor_name | Melanoma |
| mesh[3].qualifier_ui | Q000737 |
| mesh[3].descriptor_ui | D002266 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | chemistry |
| mesh[3].descriptor_name | Carboxymethylcellulose Sodium |
| mesh[4].qualifier_ui | Q000494 |
| mesh[4].descriptor_ui | D002266 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | pharmacology |
| mesh[4].descriptor_name | Carboxymethylcellulose Sodium |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D009339 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Needles |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D045744 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Cell Line, Tumor |
| mesh[7].qualifier_ui | Q000737 |
| mesh[7].descriptor_ui | D011134 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | chemistry |
| mesh[7].descriptor_name | Polysaccharides |
| mesh[8].qualifier_ui | Q000494 |
| mesh[8].descriptor_ui | D011134 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | pharmacology |
| mesh[8].descriptor_name | Polysaccharides |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D062028 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Bioprinting |
| mesh[10].qualifier_ui | Q000187 |
| mesh[10].descriptor_ui | D002470 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | drug effects |
| mesh[10].descriptor_name | Cell Survival |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D066330 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Printing, Three-Dimensional |
| mesh[12].qualifier_ui | Q000494 |
| mesh[12].descriptor_ui | D000970 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | pharmacology |
| mesh[12].descriptor_name | Antineoplastic Agents |
| mesh[13].qualifier_ui | Q000737 |
| mesh[13].descriptor_ui | D000970 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | chemistry |
| mesh[13].descriptor_name | Antineoplastic Agents |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D016503 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Drug Delivery Systems |
| type | article |
| title | Carboxymethylcellulose-fucoidan dissolvable microneedle patches for minimally invasive melanoma treatment: Demonstration on a 3D bioprinted A375 cell line model |
| biblio.issue | Pt 2 |
| biblio.volume | 319 |
| biblio.last_page | 145320 |
| biblio.first_page | 145320 |
| grants[0].funder | https://openalex.org/F4320334779 |
| grants[0].award_id | |
| grants[0].funder_display_name | Fundação para a Ciência e a Tecnologia |
| topics[0].id | https://openalex.org/T10704 |
| topics[0].field.id | https://openalex.org/fields/30 |
| topics[0].field.display_name | Pharmacology, Toxicology and Pharmaceutics |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/3003 |
| topics[0].subfield.display_name | Pharmaceutical Science |
| topics[0].display_name | Advancements in Transdermal Drug Delivery |
| topics[1].id | https://openalex.org/T10225 |
| topics[1].field.id | https://openalex.org/fields/11 |
| topics[1].field.display_name | Agricultural and Biological Sciences |
| topics[1].score | 0.9900000095367432 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1106 |
| topics[1].subfield.display_name | Food Science |
| topics[1].display_name | Essential Oils and Antimicrobial Activity |
| topics[2].id | https://openalex.org/T11569 |
| topics[2].field.id | https://openalex.org/fields/22 |
| topics[2].field.display_name | Engineering |
| topics[2].score | 0.9866999983787537 |
| topics[2].domain.id | https://openalex.org/domains/3 |
| topics[2].domain.display_name | Physical Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2204 |
| topics[2].subfield.display_name | Biomedical Engineering |
| topics[2].display_name | Optical Coherence Tomography Applications |
| funders[0].id | https://openalex.org/F4320334779 |
| funders[0].ror | https://ror.org/00snfqn58 |
| funders[0].display_name | Fundação para a Ciência e a Tecnologia |
| is_xpac | False |
| apc_list.value | 4100 |
| apc_list.currency | USD |
| apc_list.value_usd | 4100 |
| apc_paid.value | 4100 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 4100 |
| concepts[0].id | https://openalex.org/C2775909754 |
| concepts[0].level | 3 |
| concepts[0].score | 0.9303427934646606 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1144687 |
| concepts[0].display_name | Fucoidan |
| concepts[1].id | https://openalex.org/C2779718196 |
| concepts[1].level | 3 |
| concepts[1].score | 0.5926896333694458 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q17018741 |
| concepts[1].display_name | 3D bioprinting |
| concepts[2].id | https://openalex.org/C185592680 |
| concepts[2].level | 0 |
| concepts[2].score | 0.3623282313346863 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[2].display_name | Chemistry |
| concepts[3].id | https://openalex.org/C136229726 |
| concepts[3].level | 1 |
| concepts[3].score | 0.30851179361343384 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q327092 |
| concepts[3].display_name | Biomedical engineering |
| concepts[4].id | https://openalex.org/C100817775 |
| concepts[4].level | 2 |
| concepts[4].score | 0.27856412529945374 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q134219 |
| concepts[4].display_name | Polysaccharide |
| concepts[5].id | https://openalex.org/C71924100 |
| concepts[5].level | 0 |
| concepts[5].score | 0.26703619956970215 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[5].display_name | Medicine |
| concepts[6].id | https://openalex.org/C49892992 |
| concepts[6].level | 2 |
| concepts[6].score | 0.08843716979026794 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q1540285 |
| concepts[6].display_name | Tissue engineering |
| concepts[7].id | https://openalex.org/C55493867 |
| concepts[7].level | 1 |
| concepts[7].score | 0.06827971339225769 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[7].display_name | Biochemistry |
| keywords[0].id | https://openalex.org/keywords/fucoidan |
| keywords[0].score | 0.9303427934646606 |
| keywords[0].display_name | Fucoidan |
| keywords[1].id | https://openalex.org/keywords/3d-bioprinting |
| keywords[1].score | 0.5926896333694458 |
| keywords[1].display_name | 3D bioprinting |
| keywords[2].id | https://openalex.org/keywords/chemistry |
| keywords[2].score | 0.3623282313346863 |
| keywords[2].display_name | Chemistry |
| keywords[3].id | https://openalex.org/keywords/biomedical-engineering |
| keywords[3].score | 0.30851179361343384 |
| keywords[3].display_name | Biomedical engineering |
| keywords[4].id | https://openalex.org/keywords/polysaccharide |
| keywords[4].score | 0.27856412529945374 |
| keywords[4].display_name | Polysaccharide |
| keywords[5].id | https://openalex.org/keywords/medicine |
| keywords[5].score | 0.26703619956970215 |
| keywords[5].display_name | Medicine |
| keywords[6].id | https://openalex.org/keywords/tissue-engineering |
| keywords[6].score | 0.08843716979026794 |
| keywords[6].display_name | Tissue engineering |
| keywords[7].id | https://openalex.org/keywords/biochemistry |
| keywords[7].score | 0.06827971339225769 |
| keywords[7].display_name | Biochemistry |
| language | en |
| locations[0].id | doi:10.1016/j.ijbiomac.2025.145320 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S83853393 |
| locations[0].source.issn | 0141-8130, 1879-0003 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0141-8130 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | International Journal of Biological Macromolecules |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | International Journal of Biological Macromolecules |
| locations[0].landing_page_url | https://doi.org/10.1016/j.ijbiomac.2025.145320 |
| locations[1].id | pmid:40532993 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | International journal of biological macromolecules |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40532993 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5032883853 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-8015-5904 |
| authorships[0].author.display_name | Ana C. Q. Silva |
| authorships[0].countries | PT |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I60858718 |
| authorships[0].affiliations[0].raw_affiliation_string | CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal. |
| authorships[0].institutions[0].id | https://openalex.org/I60858718 |
| authorships[0].institutions[0].ror | https://ror.org/00nt41z93 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I60858718 |
| authorships[0].institutions[0].country_code | PT |
| authorships[0].institutions[0].display_name | University of Aveiro |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ana C Q Silva |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal. |
| authorships[1].author.id | https://openalex.org/A5003835412 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-5306-1996 |
| authorships[1].author.display_name | Maria C. Teixeira |
| authorships[1].countries | PT |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I60858718 |
| authorships[1].affiliations[0].raw_affiliation_string | CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal. |
| authorships[1].institutions[0].id | https://openalex.org/I60858718 |
| authorships[1].institutions[0].ror | https://ror.org/00nt41z93 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I60858718 |
| authorships[1].institutions[0].country_code | PT |
| authorships[1].institutions[0].display_name | University of Aveiro |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Maria C Teixeira |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal. |
| authorships[2].author.id | https://openalex.org/A5065768636 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-7425-9750 |
| authorships[2].author.display_name | Ana Jesus |
| authorships[2].countries | PT |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I182534213 |
| authorships[2].affiliations[0].raw_affiliation_string | Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal; UCIBIO - Applied Molecular Biosciences Unit, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal; i4HB - Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal. |
| authorships[2].institutions[0].id | https://openalex.org/I182534213 |
| authorships[2].institutions[0].ror | https://ror.org/043pwc612 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I182534213 |
| authorships[2].institutions[0].country_code | PT |
| authorships[2].institutions[0].display_name | Universidade do Porto |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Ana Jesus |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal; UCIBIO - Applied Molecular Biosciences Unit, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal; i4HB - Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal. |
| authorships[3].author.id | https://openalex.org/A5024235250 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-1152-3398 |
| authorships[3].author.display_name | Paulo Costa |
| authorships[3].countries | PT |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I182534213 |
| authorships[3].affiliations[0].raw_affiliation_string | i4HB - Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal; UCIBIO - Applied Molecular Biosciences Unit, MedTech, Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal. |
| authorships[3].institutions[0].id | https://openalex.org/I182534213 |
| authorships[3].institutions[0].ror | https://ror.org/043pwc612 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I182534213 |
| authorships[3].institutions[0].country_code | PT |
| authorships[3].institutions[0].display_name | Universidade do Porto |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Paulo C Costa |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | i4HB - Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal; UCIBIO - Applied Molecular Biosciences Unit, MedTech, Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal. |
| authorships[4].author.id | https://openalex.org/A5029363386 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-1498-048X |
| authorships[4].author.display_name | Isabel F. Almeida |
| authorships[4].countries | PT |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I182534213 |
| authorships[4].affiliations[0].raw_affiliation_string | Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal; UCIBIO - Applied Molecular Biosciences Unit, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal; i4HB - Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal. |
| authorships[4].institutions[0].id | https://openalex.org/I182534213 |
| authorships[4].institutions[0].ror | https://ror.org/043pwc612 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I182534213 |
| authorships[4].institutions[0].country_code | PT |
| authorships[4].institutions[0].display_name | Universidade do Porto |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Isabel F Almeida |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal; UCIBIO - Applied Molecular Biosciences Unit, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal; i4HB - Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal. |
| authorships[5].author.id | https://openalex.org/A5057026560 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-8845-794X |
| authorships[5].author.display_name | Patrícia Dias‐Pereira |
| authorships[5].countries | PT |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I182534213, https://openalex.org/I4210138594 |
| authorships[5].affiliations[0].raw_affiliation_string | Institute of Biomedical Sciences Abel Salazar, ICBAS-UPorto, University of Porto, 4050-313 Porto, Portugal; LAQV/REQUIMTE - Associated Laboratory for Green Chemistry, University of Porto, 4050-313 Porto, Portugal. |
| authorships[5].institutions[0].id | https://openalex.org/I4210138594 |
| authorships[5].institutions[0].ror | https://ror.org/04j14t006 |
| authorships[5].institutions[0].type | nonprofit |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210138594 |
| authorships[5].institutions[0].country_code | PT |
| authorships[5].institutions[0].display_name | Rede de Química e Tecnologia |
| authorships[5].institutions[1].id | https://openalex.org/I182534213 |
| authorships[5].institutions[1].ror | https://ror.org/043pwc612 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I182534213 |
| authorships[5].institutions[1].country_code | PT |
| authorships[5].institutions[1].display_name | Universidade do Porto |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Patrícia Dias-Pereira |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Institute of Biomedical Sciences Abel Salazar, ICBAS-UPorto, University of Porto, 4050-313 Porto, Portugal; LAQV/REQUIMTE - Associated Laboratory for Green Chemistry, University of Porto, 4050-313 Porto, Portugal. |
| authorships[6].author.id | https://openalex.org/A5038017431 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-3731-8683 |
| authorships[6].author.display_name | Inês Correia‐Sá |
| authorships[6].countries | PT |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I182534213 |
| authorships[6].affiliations[0].raw_affiliation_string | Surgery and Physiology Department, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal. |
| authorships[6].institutions[0].id | https://openalex.org/I182534213 |
| authorships[6].institutions[0].ror | https://ror.org/043pwc612 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I182534213 |
| authorships[6].institutions[0].country_code | PT |
| authorships[6].institutions[0].display_name | Universidade do Porto |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Inês Correia-Sá |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Surgery and Physiology Department, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal. |
| authorships[7].author.id | https://openalex.org/A5038741855 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-4673-0696 |
| authorships[7].author.display_name | Helena Oliveira |
| authorships[7].countries | PT |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I60858718 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Biology & CESAM, University of Aveiro, 3810-193 Aveiro, Portugal. |
| authorships[7].institutions[0].id | https://openalex.org/I60858718 |
| authorships[7].institutions[0].ror | https://ror.org/00nt41z93 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I60858718 |
| authorships[7].institutions[0].country_code | PT |
| authorships[7].institutions[0].display_name | University of Aveiro |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Helena Oliveira |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Biology & CESAM, University of Aveiro, 3810-193 Aveiro, Portugal. |
| authorships[8].author.id | https://openalex.org/A5010678341 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-5403-8416 |
| authorships[8].author.display_name | Armando J. D. Silvestre |
| authorships[8].countries | PT |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I60858718 |
| authorships[8].affiliations[0].raw_affiliation_string | CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal. |
| authorships[8].institutions[0].id | https://openalex.org/I60858718 |
| authorships[8].institutions[0].ror | https://ror.org/00nt41z93 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I60858718 |
| authorships[8].institutions[0].country_code | PT |
| authorships[8].institutions[0].display_name | University of Aveiro |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Armando J D Silvestre |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal. |
| authorships[9].author.id | https://openalex.org/A5039897497 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-9212-2704 |
| authorships[9].author.display_name | Carla Vilela |
| authorships[9].countries | PT |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I60858718 |
| authorships[9].affiliations[0].raw_affiliation_string | CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal. |
| authorships[9].institutions[0].id | https://openalex.org/I60858718 |
| authorships[9].institutions[0].ror | https://ror.org/00nt41z93 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I60858718 |
| authorships[9].institutions[0].country_code | PT |
| authorships[9].institutions[0].display_name | University of Aveiro |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Carla Vilela |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal. |
| authorships[10].author.id | https://openalex.org/A5034289951 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-6320-4663 |
| authorships[10].author.display_name | Carmen S. R. Freire |
| authorships[10].countries | PT |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I60858718 |
| authorships[10].affiliations[0].raw_affiliation_string | CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal. Electronic address: [email protected]. |
| authorships[10].institutions[0].id | https://openalex.org/I60858718 |
| authorships[10].institutions[0].ror | https://ror.org/00nt41z93 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I60858718 |
| authorships[10].institutions[0].country_code | PT |
| authorships[10].institutions[0].display_name | University of Aveiro |
| authorships[10].author_position | last |
| authorships[10].raw_author_name | Carmen S R Freire |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal. Electronic address: [email protected]. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1016/j.ijbiomac.2025.145320 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Carboxymethylcellulose-fucoidan dissolvable microneedle patches for minimally invasive melanoma treatment: Demonstration on a 3D bioprinted A375 cell line model |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10704 |
| primary_topic.field.id | https://openalex.org/fields/30 |
| primary_topic.field.display_name | Pharmacology, Toxicology and Pharmaceutics |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/3003 |
| primary_topic.subfield.display_name | Pharmaceutical Science |
| primary_topic.display_name | Advancements in Transdermal Drug Delivery |
| related_works | https://openalex.org/W4387497383, https://openalex.org/W2948807893, https://openalex.org/W2899084033, https://openalex.org/W2778153218, https://openalex.org/W2748952813, https://openalex.org/W1531601525, https://openalex.org/W4391375266, https://openalex.org/W1504544302, https://openalex.org/W3145578056, https://openalex.org/W3093984226 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1016/j.ijbiomac.2025.145320 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S83853393 |
| best_oa_location.source.issn | 0141-8130, 1879-0003 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0141-8130 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | International Journal of Biological Macromolecules |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | International Journal of Biological Macromolecules |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.ijbiomac.2025.145320 |
| primary_location.id | doi:10.1016/j.ijbiomac.2025.145320 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S83853393 |
| primary_location.source.issn | 0141-8130, 1879-0003 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0141-8130 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | International Journal of Biological Macromolecules |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | International Journal of Biological Macromolecules |
| primary_location.landing_page_url | https://doi.org/10.1016/j.ijbiomac.2025.145320 |
| publication_date | 2025-06-16 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4385215048, https://openalex.org/W4220856798, https://openalex.org/W4282925519, https://openalex.org/W4391718268, https://openalex.org/W3009972534, https://openalex.org/W4390467755, https://openalex.org/W2924560003, https://openalex.org/W2031593698, https://openalex.org/W2152671209, https://openalex.org/W3167009875, https://openalex.org/W4375947423, https://openalex.org/W2791000044, https://openalex.org/W3027814755, https://openalex.org/W4297477863, https://openalex.org/W4379802922, https://openalex.org/W3208950804, https://openalex.org/W3007687819, https://openalex.org/W6780447635, https://openalex.org/W2941948770, https://openalex.org/W6860399941, https://openalex.org/W4294733089, https://openalex.org/W3115781608, https://openalex.org/W3216055019, https://openalex.org/W4380853104, https://openalex.org/W4387826254, https://openalex.org/W6851926918, https://openalex.org/W6858899453, https://openalex.org/W4317754433, https://openalex.org/W4385969691, https://openalex.org/W4210587698, https://openalex.org/W4300690215, https://openalex.org/W3023514077, https://openalex.org/W2065845122, https://openalex.org/W4403843586, https://openalex.org/W2789853984, https://openalex.org/W2183135309, https://openalex.org/W3044546106, https://openalex.org/W2041250960, https://openalex.org/W2922316343, https://openalex.org/W2053059779, https://openalex.org/W2010973187, https://openalex.org/W3104974074, https://openalex.org/W2962728427, https://openalex.org/W2984009430, https://openalex.org/W6815895403, https://openalex.org/W2013315584, https://openalex.org/W3016783788, https://openalex.org/W4291152128, https://openalex.org/W647747511, https://openalex.org/W2054294261, https://openalex.org/W2561807938, https://openalex.org/W4360951500, https://openalex.org/W2323779125, https://openalex.org/W2920627142, https://openalex.org/W2905326325, https://openalex.org/W3211916953, https://openalex.org/W4378173361, https://openalex.org/W4389443415, https://openalex.org/W4391179490, https://openalex.org/W4361027110 |
| referenced_works_count | 60 |
| abstract_inverted_index.N | 87 |
| abstract_inverted_index.a | 18, 58, 82, 93, 160, 167, 175 |
| abstract_inverted_index.%) | 173 |
| abstract_inverted_index.12 | 140 |
| abstract_inverted_index.2D | 168 |
| abstract_inverted_index.3D | 176 |
| abstract_inverted_index.48 | 185 |
| abstract_inverted_index.56 | 182 |
| abstract_inverted_index.83 | 172 |
| abstract_inverted_index.In | 11, 142 |
| abstract_inverted_index.an | 126 |
| abstract_inverted_index.ex | 112 |
| abstract_inverted_index.h. | 186 |
| abstract_inverted_index.in | 92, 111, 125, 165 |
| abstract_inverted_index.of | 25, 38, 46, 51, 74, 85, 100, 120, 135, 150, 199 |
| abstract_inverted_index.on | 154 |
| abstract_inverted_index.or | 27 |
| abstract_inverted_index.to | 5, 103, 106, 159 |
| abstract_inverted_index.up | 105 |
| abstract_inverted_index.we | 42 |
| abstract_inverted_index.%), | 183 |
| abstract_inverted_index.381 | 107 |
| abstract_inverted_index.456 | 75 |
| abstract_inverted_index.MNs | 102, 137, 153 |
| abstract_inverted_index.The | 64, 187 |
| abstract_inverted_index.and | 9, 54, 60, 69, 77, 174 |
| abstract_inverted_index.for | 21, 194 |
| abstract_inverted_index.the | 35, 39, 44, 98, 132, 136, 147, 151 |
| abstract_inverted_index.(ca. | 171, 181 |
| abstract_inverted_index.1.07 | 86 |
| abstract_inverted_index.A375 | 155 |
| abstract_inverted_index.both | 166 |
| abstract_inverted_index.cell | 162, 169 |
| abstract_inverted_index.min. | 141 |
| abstract_inverted_index.show | 191 |
| abstract_inverted_index.skin | 95, 115, 129 |
| abstract_inverted_index.this | 12 |
| abstract_inverted_index.tips | 71, 138 |
| abstract_inverted_index.vivo | 113 |
| abstract_inverted_index.with | 30, 72, 117 |
| abstract_inverted_index.μm, | 76, 108 |
| abstract_inverted_index.μm. | 122 |
| abstract_inverted_index.(CMC) | 53 |
| abstract_inverted_index.(Fuc) | 56 |
| abstract_inverted_index.(MNs) | 16 |
| abstract_inverted_index.after | 184 |
| abstract_inverted_index.drugs | 26 |
| abstract_inverted_index.force | 84 |
| abstract_inverted_index.great | 192 |
| abstract_inverted_index.human | 114 |
| abstract_inverted_index.model | 96, 130, 180 |
| abstract_inverted_index.often | 1 |
| abstract_inverted_index.sharp | 70 |
| abstract_inverted_index.skin. | 40 |
| abstract_inverted_index.tests | 91 |
| abstract_inverted_index.tumor | 7 |
| abstract_inverted_index.using | 57 |
| abstract_inverted_index.vitro | 143 |
| abstract_inverted_index.assays | 145 |
| abstract_inverted_index.avenue | 20 |
| abstract_inverted_index.bodies | 68 |
| abstract_inverted_index.cells, | 157 |
| abstract_inverted_index.combat | 6 |
| abstract_inverted_index.deeper | 36 |
| abstract_inverted_index.depths | 119 |
| abstract_inverted_index.effect | 149 |
| abstract_inverted_index.layers | 37 |
| abstract_inverted_index.robust | 78 |
| abstract_inverted_index.simple | 59 |
| abstract_inverted_index.within | 139 |
| abstract_inverted_index.325-453 | 121 |
| abstract_inverted_index.CMC_Fuc | 101, 152, 188 |
| abstract_inverted_index.Herein, | 41 |
| abstract_inverted_index.ability | 99 |
| abstract_inverted_index.agarose | 127 |
| abstract_inverted_index.culture | 170, 179 |
| abstract_inverted_index.further | 109 |
| abstract_inverted_index.heights | 73 |
| abstract_inverted_index.leading | 158 |
| abstract_inverted_index.maximum | 83 |
| abstract_inverted_index.natural | 31 |
| abstract_inverted_index.present | 17 |
| abstract_inverted_index.promise | 193 |
| abstract_inverted_index.samples | 116 |
| abstract_inverted_index.studies | 124 |
| abstract_inverted_index.systems | 15, 190 |
| abstract_inverted_index.therapy | 4 |
| abstract_inverted_index.Melanoma | 0 |
| abstract_inverted_index.adjuvant | 3, 197 |
| abstract_inverted_index.complete | 133 |
| abstract_inverted_index.composed | 50 |
| abstract_inverted_index.context, | 13 |
| abstract_inverted_index.delivery | 24 |
| abstract_inverted_index.describe | 43 |
| abstract_inverted_index.fucoidan | 55 |
| abstract_inverted_index.hydrogel | 128 |
| abstract_inverted_index.integral | 67 |
| abstract_inverted_index.invasive | 23, 196 |
| abstract_inverted_index.melanoma | 156, 178 |
| abstract_inverted_index.reaching | 81 |
| abstract_inverted_index.requires | 2 |
| abstract_inverted_index.revealed | 131 |
| abstract_inverted_index.unveiled | 146 |
| abstract_inverted_index.bioactive | 28, 47 |
| abstract_inverted_index.compounds | 29 |
| abstract_inverted_index.insertion | 90, 118 |
| abstract_inverted_index.melanoma. | 200 |
| abstract_inverted_index.minimally | 22, 195 |
| abstract_inverted_index.penetrate | 104 |
| abstract_inverted_index.polymeric | 94 |
| abstract_inverted_index.promising | 19 |
| abstract_inverted_index.reduction | 164 |
| abstract_inverted_index.showcased | 66 |
| abstract_inverted_index.targeting | 34 |
| abstract_inverted_index.treatment | 198 |
| abstract_inverted_index.validated | 110 |
| abstract_inverted_index.viability | 163 |
| abstract_inverted_index.anticancer | 32 |
| abstract_inverted_index.bioprinted | 177 |
| abstract_inverted_index.dissolving | 48 |
| abstract_inverted_index.mechanical | 79 |
| abstract_inverted_index.technique. | 63 |
| abstract_inverted_index.Dissolution | 123 |
| abstract_inverted_index.Preliminary | 89 |
| abstract_inverted_index.antitumoral | 148 |
| abstract_inverted_index.dissolution | 134 |
| abstract_inverted_index.fabrication | 45 |
| abstract_inverted_index.metastasis. | 10 |
| abstract_inverted_index.microneedle | 14, 189 |
| abstract_inverted_index.properties, | 33, 80 |
| abstract_inverted_index.significant | 161 |
| abstract_inverted_index.cytotoxicity | 144 |
| abstract_inverted_index.demonstrated | 97 |
| abstract_inverted_index.eco-friendly | 61 |
| abstract_inverted_index.micromolding | 62 |
| abstract_inverted_index.microneedles | 49, 65 |
| abstract_inverted_index.proliferation | 8 |
| abstract_inverted_index.needle<sup>-1</sup>. | 88 |
| abstract_inverted_index.carboxymethylcellulose | 52 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 91 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 11 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/2 |
| sustainable_development_goals[0].score | 0.7799999713897705 |
| sustainable_development_goals[0].display_name | Zero hunger |
| citation_normalized_percentile.value | 0.81026911 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |